NO325393B1 - Forbindelse, referansepreparat som inneholder forbindelsen, anvendelse av forbindelsen til a bestemme genotoksiske urenheter og fremgangsmater derav - Google Patents

Forbindelse, referansepreparat som inneholder forbindelsen, anvendelse av forbindelsen til a bestemme genotoksiske urenheter og fremgangsmater derav Download PDF

Info

Publication number
NO325393B1
NO325393B1 NO20006444A NO20006444A NO325393B1 NO 325393 B1 NO325393 B1 NO 325393B1 NO 20006444 A NO20006444 A NO 20006444A NO 20006444 A NO20006444 A NO 20006444A NO 325393 B1 NO325393 B1 NO 325393B1
Authority
NO
Norway
Prior art keywords
compound
levosimendan
stated
solution
samples
Prior art date
Application number
NO20006444A
Other languages
English (en)
Norwegian (no)
Other versions
NO20006444D0 (no
NO20006444L (no
Inventor
Reijo Johannes Backstrom
Tuula Heinonen
Tuula Hauta-Aho
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of NO20006444D0 publication Critical patent/NO20006444D0/no
Publication of NO20006444L publication Critical patent/NO20006444L/no
Publication of NO325393B1 publication Critical patent/NO325393B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G01N2030/042—Standards
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
NO20006444A 1998-06-18 2000-12-15 Forbindelse, referansepreparat som inneholder forbindelsen, anvendelse av forbindelsen til a bestemme genotoksiske urenheter og fremgangsmater derav NO325393B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI981428A FI104718B (fi) 1998-06-18 1998-06-18 [[4-(2-atsido-3-metyyli-5-oksotetrahydrofuran-2-yyli)fenyyli]hydratsono]propaanidinitriili käytettäväksi referenssiaineena levosimendaanierien analyysissä
PCT/FI1999/000539 WO1999065888A2 (en) 1998-06-18 1999-06-18 A reference compound for use in the analysis of levosimendan batches

Publications (3)

Publication Number Publication Date
NO20006444D0 NO20006444D0 (no) 2000-12-15
NO20006444L NO20006444L (no) 2000-12-15
NO325393B1 true NO325393B1 (no) 2008-04-21

Family

ID=8552039

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006444A NO325393B1 (no) 1998-06-18 2000-12-15 Forbindelse, referansepreparat som inneholder forbindelsen, anvendelse av forbindelsen til a bestemme genotoksiske urenheter og fremgangsmater derav

Country Status (27)

Country Link
US (1) US6340764B1 (cs)
EP (1) EP1087956B1 (cs)
JP (1) JP4550279B2 (cs)
KR (1) KR100661772B1 (cs)
CN (1) CN1129590C (cs)
AR (1) AR018879A1 (cs)
AT (1) ATE253566T1 (cs)
AU (1) AU755699B2 (cs)
BR (1) BR9911230A (cs)
CA (1) CA2334864C (cs)
CZ (1) CZ298659B6 (cs)
DE (1) DE69912604D1 (cs)
EA (1) EA002854B1 (cs)
ES (1) ES2211113T3 (cs)
FI (1) FI104718B (cs)
HR (1) HRP20000866B1 (cs)
HU (1) HU229582B1 (cs)
ID (1) ID29239A (cs)
IL (1) IL139964A (cs)
MX (1) MXPA00012436A (cs)
NO (1) NO325393B1 (cs)
NZ (1) NZ508557A (cs)
PL (1) PL201772B1 (cs)
RS (1) RS49929B (cs)
SK (1) SK284353B6 (cs)
WO (1) WO1999065888A2 (cs)
ZA (1) ZA200006993B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007532686A (ja) 2004-04-21 2007-11-15 テバ ファーマシューティカル インダストリーズ リミティド モンテルカストナトリウムを調製する方法
FR2877013A1 (fr) * 2004-10-27 2006-04-28 Assist Publ Hopitaux De Paris Indentification d'une mutation de jak2 impliquee dans la polyglobulie de vaquez
KR100899585B1 (ko) 2005-07-05 2009-05-27 테바 파마슈티컬 인더스트리즈 리미티드 몬테루카스트의 정제
CN104230816B (zh) * 2014-09-19 2017-02-15 成都新恒创药业有限公司 一种左西孟旦潜在基因毒性杂质及其制备、检测方法
CN104478809B (zh) * 2014-11-14 2016-08-17 成都新恒创药业有限公司 一种左西孟旦杂质及其制备和检测方法
CN105817632A (zh) * 2015-01-09 2016-08-03 中国科学院宁波材料技术与工程研究所 片状粉末的制备装置及方法
CN105784895B (zh) * 2015-10-30 2018-05-22 成都欣捷高新技术开发有限公司 一种用高效液相色谱仪检测左西孟旦中杂质的方法
CN111474289A (zh) * 2019-10-31 2020-07-31 武汉嘉诺康医药技术有限公司 一种利用反相色谱分离分析左西孟旦中右西孟旦的方法
CA3161960A1 (en) 2019-12-16 2021-06-24 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hfpef)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB383449A (en) * 1931-12-12 1932-11-17 Percy Charles Barton Improvements relating to masts, poles, or like supports and their manufacture
GB565546A (en) * 1943-04-13 1944-11-15 Leslie Frederick Reeve A pneumatically operated pickup unit for use in electric organs and the like
FI894035A7 (fi) * 1988-09-07 1990-03-08 Orion Yhtymae Oy Foerfarande foer framstaellning av nya substituerade pyridazinoner.
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9606474D0 (en) * 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
GB9915179D0 (en) * 1999-06-29 1999-09-01 Orion Corp A method for the treatment or prevention of coronary graft vasospasm

Also Published As

Publication number Publication date
CA2334864A1 (en) 1999-12-23
NZ508557A (en) 2002-05-31
BR9911230A (pt) 2001-03-06
FI981428L (fi) 1999-12-19
HUP0102020A2 (hu) 2001-12-28
HRP20000866B1 (en) 2009-02-28
FI981428A0 (fi) 1998-06-18
CN1306527A (zh) 2001-08-01
JP4550279B2 (ja) 2010-09-22
PL201772B1 (pl) 2009-05-29
EA200100055A1 (ru) 2001-06-25
NO20006444D0 (no) 2000-12-15
AU4786399A (en) 2000-01-05
EP1087956B1 (en) 2003-11-05
HK1032779A1 (en) 2001-08-03
EA002854B1 (ru) 2002-10-31
ES2211113T3 (es) 2004-07-01
NO20006444L (no) 2000-12-15
MXPA00012436A (es) 2002-06-04
CA2334864C (en) 2008-01-15
HU229582B1 (en) 2014-02-28
SK284353B6 (sk) 2005-02-04
EP1087956A2 (en) 2001-04-04
ATE253566T1 (de) 2003-11-15
HRP20000866A2 (en) 2001-12-31
CZ20004555A3 (en) 2001-05-16
PL347577A1 (en) 2002-04-08
KR100661772B1 (ko) 2006-12-28
DE69912604D1 (de) 2003-12-11
CZ298659B6 (cs) 2007-12-12
WO1999065888A2 (en) 1999-12-23
US6340764B1 (en) 2002-01-22
FI104718B (fi) 2000-03-31
RS49929B (sr) 2008-09-29
IL139964A (en) 2003-07-06
ZA200006993B (en) 2002-02-28
KR20010072622A (ko) 2001-07-31
WO1999065888A3 (en) 2000-01-27
SK18722000A3 (sk) 2001-09-11
CN1129590C (zh) 2003-12-03
ID29239A (id) 2001-08-16
IL139964A0 (en) 2002-02-10
AR018879A1 (es) 2001-12-12
JP2002518383A (ja) 2002-06-25
YU76700A (sh) 2002-11-15
HUP0102020A3 (en) 2002-04-29
AU755699B2 (en) 2002-12-19

Similar Documents

Publication Publication Date Title
KR100322354B1 (ko) 화합물 및 그의 용도
UA79229C2 (en) 3-nitrogen-6,7-dioxygen steroids and uses related thereto
US20080287680A1 (en) Solifenacin Succinate-Containing Composition
NO325393B1 (no) Forbindelse, referansepreparat som inneholder forbindelsen, anvendelse av forbindelsen til a bestemme genotoksiske urenheter og fremgangsmater derav
CN109705071A (zh) Hdac抑制剂及其制备方法和用途
Palazzino et al. 1, 3-Diarylpyrazolo [4, 5-c]-and-[5, 4-c] quinolin-4-ones. 4. Synthesis and specific inhibition of benzodiazepine receptor binding
EP1441224B1 (en) Enzyme inhibition immunoassay
JP2008510020A (ja) アナストロゾール中間体の不純物及びその使用
JP2008510020A6 (ja) アナストロゾール中間体の不純物及びその使用
SU1540656A3 (ru) Способ получени стероидов или их фармацевтически приемлемых солей
KR890003838B1 (ko) 인데노피리미딘 유도체
JP4279718B2 (ja) Ｍｐｔｐ親和性標識
HK1032779B (en) A reference compound for use in the analysis of levosimendan batches
PL199365B1 (pl) Sposób wydzielania N-(4-trifluorometylofenylo)-5-metylo-izoksazolo-4-karboksyamidu
Lu et al. Biliary and urinary metabolic profiles of 1, 2-diethyl-3-hydroxypyridin-4-one (CP94) in the rat
EP3966565B1 (en) Mixture of isomers of aminaphtone, analytical method for identifying them and pharmaceutical composition comprising said isomers
CA2528952A1 (en) Process for the synthesis of high purity d-(17alpha)-13-ethyl-17­hydroxy-18,19-dinorpre:gn-4-ene-20-yne-3-one-oxime
CN114805200A (zh) 一种盐酸丙卡特罗杂质及其制备方法和用途

Legal Events

Date Code Title Description
MK1K Patent expired